(Q41465576)

1 October 2017

1 reference

title

The antiandrogen withdrawal syndrome (English)

1 reference

1 October 2017

Wirth MP

1

1 reference

PubMed ID

9144890

1 October 2017

Froschermaier SE

series ordinal

2

1 reference

1 October 2017

1 January 1997

1 reference

1 October 2017

1 reference

1 October 2017

25 Suppl 2

1 reference

1 October 2017

S67-71

1 reference

Androgen receptor gene mutations in human prostate cancer

1 October 2017

1 reference

12 December 2020

Effect of High-dose Medroxyprogesterone Acetate on Plasma Hormone Levels and Pain Relief in Patients with Advanced Prostatic Cancer

1 reference

12 December 2020

Cancer statistics, 1992

1 reference

12 December 2020

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

12 December 2020

Tamoxifen withdrawal response. Report of a case

1 reference

12 December 2020

Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens

1 reference

12 December 2020

Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma

1 reference

12 December 2020

Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer

1 reference

12 December 2020

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome

1 reference

12 December 2020

Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamide

1 reference

12 December 2020

Withdrawal phenomenon with the antiandrogen casodex

1 reference

12 December 2020

Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer

1 reference

12 December 2020

Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate

1 reference

12 December 2020

Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome

1 reference

12 December 2020

Molecular implications of the antiandrogen withdrawal syndrome

1 reference

12 December 2020

Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome

1 reference

12 December 2020

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer

1 reference

12 December 2020

Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy

1 reference

12 December 2020

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

12 December 2020

Complete remission of hormone refractory adenocarcinoma of the prostate in response to withdrawal of diethylstilbestrol

1 reference

12 December 2020

Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

1 reference

12 December 2020

Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers

1 reference

12 December 2020

Androgen receptor gene mutations in human prostate cancer

1 reference

12 December 2020

Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal

1 reference

12 December 2020

Androgen receptor status of lymph node metastases from prostate cancer

1 reference

12 December 2020

Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00941991

1 reference

1 October 2017

1 reference

PubMed ID

9144890